Dominic Catanese, DPM
Podiatrist · Bronx, NYNPI 1932284239
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (42.9%), education and travel and lodging — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Gotham Surgical Solutions & Devices, Inc. at 29.5% of the total. Reporting peaked in 2019 at $4,239 and has fallen 75.7% since, to $1,031 in 2025. Among podiatrist clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 90 payments — averaging $127.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gotham Surgical Solutions & Devices, Inc.$3K
- Medical Device Business Services, Inc.$2K
- Linvatec Corporation$1K
- Paratek Pharmaceuticals, Inc.$897
- Stryker$482
- Arthrex$461
- plus $3K from 13 others
What the payments were for
- Consulting fees$1,54013%
- Travel & lodging$2,16519%
- Food & beverage$4,91043%
- Education$2,83725%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gotham Surgical Solutions & Devices, Inc. | 7 | $3,382 |
| Medical Device Business Services, Inc. | 8 | $2,428 |
| Linvatec Corporation | 7 | $1,224 |
| Paratek Pharmaceuticals, Inc. | 9 | $897 |
| Stryker | 9 | $482 |
| Arthrex | 5 | $461 |
| Smith+Nephew | 12 | $422 |
| Medtronic | 6 | $371 |
| Treace Medical Concepts, Inc. | 6 | $353 |
| Kerecis Limited | 4 | $324 |
| Johnson & Johnson | 4 | $234 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $227 |
| Zimmer Biomet | 2 | $185 |
| Paragon 28, Inc. | 1 | $144 |
| Melinta Therapeutics, LLC | 1 | $125 |
| Averitas Pharma Inc. | 2 | $85 |
| Advanced Oxygen Therapy Inc. | 3 | $56 |
| Dexcom, Inc. | 1 | $31 |
| Next Science LLC | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LINVATEC EXTREMITIES$1,048
- NUZYRA$863
- JUBLIA$227
- Kerecis Omega3 Wound$195
- Lapiplasty System$156
- Precision MIS Bunion$144
- TAPESTRY$140
- INTELLIS ADAPTIVESTIM$132
- Panta 2$125
- Baxdela$125
- INCEPTIV$113
- CITREFIX$105
- VARIAX$103
How this compares
$11,452 in reported general payments places this provider in the 95th percentile of 862 podiatrist providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CiclopiroxCiclopirox Olamine | 385 | $13,249 |
| SantylCollagenase Clostridium Hist. | 33 | $9,936 |
| Ammonium Lactate | 181 | $2,885 |
| Diclofenac Sodium | 34 | $1,875 |
| Naproxen | 131 | $978 |
| Nystatin | 19 | $508 |
| Ketoconazole | 13 | $467 |
| Terbinafine Hcl | 66 | $425 |
| Meloxicam | 74 | $149 |
| Methylprednisolone | 24 | $131 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 22 | $47 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $422 | $9,93633 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 862 podiatrist providers in New York.
Other podiatrist in Bronx
- Denise LevyBronx$6K
- Christopher BromleyPoughkeepsie$152K
- Scott GawlikBrooklyn$77K
- Waldemar MajdanskiAstoria$71K
- Michael HutzelSeaford$64K
- Donald RubinCorning$53K
- Steven NormanMiddle Village$42K
- Elvis DanneNew York$35K
- Adam CirlincioneGlen Cove$31K
- Jude ViolanteNiagara Falls$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.